Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
8-KReport of unscheduled material events or corporate eventDec 22, 2006View HTMLDownload DOCDownload PDFDownload XLS
4/AAmendment to a previously filed 4Dec 22, 2006View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventDec 18, 2006View HTMLDownload DOCDownload PDFDownload XLS
3Initial filing by director officer or owner of more than ten percent.Dec 18, 2006View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 18, 2006View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 18, 2006View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 14, 2006View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 8, 2006View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 30, 2006View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 22, 2006View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 22, 2006View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 22, 2006View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 22, 2006View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 22, 2006View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 22, 2006View HTMLDownload DOCDownload PDF
3Initial filing by director officer or owner of more than ten percent.Nov 22, 2006View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 22, 2006View HTMLDownload DOCDownload PDF
10-QQuarterly report which provides a continuing view of a company's financial positionNov 3, 2006View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesNov 2, 2006View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventNov 1, 2006View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventSep 25, 2006View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesAug 31, 2006View HTMLDownload DOCDownload PDF
S-8Securities offered to employees pursuant to employee benefit plansAug 29, 2006View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesAug 17, 2006View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 17, 2006View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-93

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information